Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer via cell-cell communication

Figure 8 Analysis of predicted TIDE scores in the sample. A: Pearson correlation analysis between the sample risk score and TIDE score; B-D: A comparative analysis of the TIDE score was conducted for the high-risk and low-risk groups identified by the gene signature in this article and the groups identified by the gene signatures proposed by Tang et al[11] and Wang et al[12].